Embedded Bioprinting of Breast Cancer–Adipose Composite Tissue Model for Patient‐Specific Paracrine Interaction Analysis
Advanced Healthcare Materials · 2025-01 · 14 (3)
DOI: 10.1002/adhm.202401887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 08.12.2024. Verfasst von Wonwoo Jeong und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of biomedical engineering, Ulsan National Institute of Science and Technology, 50, UNIST-gil, Ulju-gun, Ulsan, 44919, South Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Bioprinting, Adipose Tissue, Paracrine Communication. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Research Foundation of Korea, Korean government(MSIT).
Abstract (Originalsprache)
The interaction between breast cancer and stromal tissues varies significantly from patient to patient, greatly impacting cancer prognosis. However, conventional models struggle to accurately replicate these patient‐specific interactions. Herein, a novel breast cancer–adipose composite tissue model capable of precisely adjusting the inter‐tissue interaction is developed. The composite tissue model is produced through precise embedded bioprinting of breast‐cancer spheroids and live‐adipose‐tissue ink. This model possessed not only precisely patterned cancer spheroids but also well‐preserved intrinsic extracellular matrices (ECMs) and heterogeneous cell populations of adipose tissue (AT). Evaluation results successfully demonstrated that the bioprinted composite model can precisely regulate adipokine secretion, drug resistance, and cancer‐cell invasion characteristics by adjusting the distance between the cancer spheroids and adipose tissue. The utility of the model is validated using adipokine‐targeted therapies (C‐compound/SC600125 (SC), AG 490 (AG), and Metformin (MET)). Interestingly, the inhibition of cancer cell proliferation and invasion by these adipokine‐targeted drugs nearly doubled as the tissue distance decreased. This suggests that the efficacy of the drugs can be precisely evaluated using the new model. These findings underscore the potential of the developed composite model to replicate patient‐specific crosstalk, thereby offering a promising platform for the sophisticated evaluation of various breast‐cancer therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of biomedical engineering, Ulsan National Institute of Science and Technology, 50, UNIST-gil, Ulju-gun, Ulsan, 44919, South Korea.
- Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC, 27101, USA.
- Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine & Georgia Institute of Technology, Atlanta, GA, 30332, USA.
ORCID-Profile: Wonwoo Jeong, Hyun-Wook Kang
Förderung
- National Research Foundation of Korea
- Korean government(MSIT)
Zitieren
APA
Jeong, W., Han, J., Choi, J., & Kang, H. W. (2025). Embedded Bioprinting of Breast Cancer–Adipose Composite Tissue Model for Patient‐Specific Paracrine Interaction Analysis. Advanced Healthcare Materials, 14(3). https://doi.org/10.1002/adhm.202401887
Vancouver
Jeong W, Han J, Choi J, Kang HW. Embedded Bioprinting of Breast Cancer–Adipose Composite Tissue Model for Patient‐Specific Paracrine Interaction Analysis. Advanced Healthcare Materials. 2025;14(3). doi:10.1002/adhm.202401887
BibTeX
@article{Jeong2025,
author = {Jeong, Wonwoo and Han, Jonghyeuk and Choi, Jeonghan and Kang, Hyun-Wook},
title = {Embedded Bioprinting of Breast Cancer–Adipose Composite Tissue Model for Patient‐Specific Paracrine Interaction Analysis},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {3},
doi = {10.1002/adhm.202401887}
}
EUVIMED